Melanotan II
Also known as: MT-II, MT2
Clinical Status
Not approved — research discontinued due to side effects.
Mechanism of Action
Binds to MC1R (tanning) and MC4R (sexual effects). MC1R activation stimulates melanin production. MC4R activation influences sexual arousal.
Dosing Defaults
Dose
250-500 mcg
Frequency
Daily during loading, then weekly
Administration
Subcutaneous injection
Timing
Evening or before sun exposure
Food
with or without
Duration
Loading 2-3 weeks, then maintenance
Dose range: 100-1,000 mcg per dose
Pre-UV exposure timing maximizes tanning response.
Side Effects
- •Nausea
- •Facial flushing
- •Spontaneous erections
- •Darkening of moles
- •Priapism (emergency)
- •Association with melanoma risk
Contraindications & Warnings
- ⚠Melanoma history
- ⚠Numerous moles
- •Not medical advice
- •ILLEGAL in US, UK, Australia
Compare
Compare Melanotan II with another peptide side-by-side.
Ad
Related Hormonal Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.